Nanopore technology allows point-of-care SARS-CoV-2 genomic sequencing

By | July 14, 2021
As the SARS-CoV-2 continues to spread worldwide and cause disease and death on a devastating scale, genomic sequencing has become a primary method of keeping track of emerging variants and new outbreaks. A new medRxiv* preprint explores the role of nanopore sequencing in this effort.